Institutes of Biomedical Research Corp (MRES)

[Lexit]

Quebec's La Presse confirms OLLU's involvment with Neuro-Biotech.

More coverage on the Crew in this morning's La Presse

The Crew is still large and in charge.

Lots of interesting material on the "new" Neuro Biotech....LOL.. Ollu's behind it....What a surprise...and so much more:

Le groupe Cortellazzi ne lâche pas prise
La Presse Affaires - ?1 hour ago?
Le principal promoteur de Neuro Biotech est Serge Ollu, associé de longue date d'Andrea Cortellazzi. En janvier, Serge Ollu a plaidé coupable à une fraude ...

http://lapresseaffaires.cyberpresse.ca/economie/quebec/201006/23/01-4292570-le-groupe-cortellazzi-ne-lache-pas-prise.php


Google Translation:

The group Cortellazzi not let go

Publié le 23 juin 2010 à 07h12 | Mis à jour à 07h17

(Montreal) The group associated Andrea Cortellazzi just launched a new company stock, although investors have complained of being cheated with previous projects. The new shell will attempt to commercialize blood tests to measure stress.

Saturday, La Presse published an investigation into a stock market scam allegedly orchestrated Andrea Cortellazzi from his mansion in the Rue Redpath Crescent, Montreal. One of the equities mentioned by investors is called M45 Mining Resources.
But last Thursday, M45 has officially changed its name and purpose, says a document filed with the Securities
and Exchange Commission (SEC). Now, the shell market called Brain Biotech. She will specialize more in the mining sector, but in blood tests.

Serge Ollu

The main proponent of Neuro Biotech Serge Ollu, longtime associate of Andrea Cortellazzi. In January, Serge
Ollu pleaded guilty to criminal fraud in Montreal. On 10 June, in an appearance in court for sentencing, the daughter of Serge Ollu said it worked with his father in this transformation of M45 with a biotechnology company.

The objective of Serge Ollu is to raise funds to develop this business, "said Marie-Christine Raynault-Ollu, who works with his father.

The tests serve to detect such degenerative diseases as Alzheimer's. They were developed by Andrée Roberge,
at Laval University.

"It's an extremely important issue, which is important to us. Dr. Roberge has placed its confidence in him, despite
the hearings this morning, "she said.

The proposed marketing of these tests is not new. Already in 1997, Ms. Roberge tried to get his product to
market. His company was then listed on the CDNX in 1999, but the project fizzled.

Andrea Cortellazzi is still the controlling shareholder of M45, according to a report filed with the U.S. SEC in
October. In addition, two investors contacted by The Press continues to support Andrea Cortellazzi have close
relations with Serge Ollu. These investors were reimbursed $ 15,000 to $ 90,000 they demand a check from the family Ollu.

A partner canceled

Serge Ollu today acts as a consultant in the revival of business, according to his daughter. In addition to M45, he
worked for the recovery of four shells stock, including M45 and Excel Gold Mining, "she said in court.

Her daughter also said that one partner of his father in his current work is Sarkis Sarkisian. But Sarkis Sarkisian
was canceled for life business financial advisor in February. He also sentenced the largest fine ever imposed in
such a case, or $ 625,000.

The case was handled by the Investment Industry Regulatory Organization of Canada (IIROC). Essentially, the
agency said Sarkisian guilty of participating in a scheme which has lost seven CN Pensioners most of their retirement funds of 2.9 million.

Sarkis Sarkisian worked with men or companies whose integrity has been tarnished in recent years, notably
Claude Lavigne (Presidents Club), Norshield and iForum. His lawyer before IIROC Bracaglia was John, who now
represents the same Andrea Cortellazzi and Serge Ollu.
For three years, Andrea Cortellazzi and Serge Ollu have been linked by various shells stock market investors,
namely HE-5 Resources Andréanne, UMining Resources, M45 and now Neuro Biotech.

Investors have also told La Presse have been selling shares of the company Wanderport Andrea Cortellazzi last
summer, and have difficulty recovering their money. Wanderport market is a shell co-directed by Barry
Somervail, the same man who is now CEO of the new Neuro Biotech.

We tried to contact Barry Somervail headquarters of Neuro-Biotech, Montreal, and at his residence in the borough
of Saint-Laurent, but without success.


http://translate.google.ca/translate?u=http%3A%2F%2Flapresseaffaires.cyberpresse.ca%2Feconomie%2Fquebec%2F201006%2F23%2F01-4292570-le-groupe-cortellazzi-ne-lache-pas-prise.php&sl=fr&tl=en&hl=&ie=UTF-8